Systimmune Oncology Pipeline
Systimmune made its debut at a major medical congress with the goal of introducing its oncology pipeline to healthcare professionals for the first time. To make a strong first impression, they needed more than just printed materials—they needed an interactive experience that could clearly communicate the science behind their therapies, showcase their pipeline strategy, and invite deeper exploration. 2Pixels delivered a multi-platform solution that positioned Systimmune as an innovative and credible player in the oncology space.
Client
Systimmune, Inc.
Exhibit House
BlueHive
Services
Concept | Design | Programming
The Challenge
The project needed to support three unique platforms: the corporate website, an interactive experience for the exhibit floor, and a mobile-friendly version for tablets and phones. Each environment had its own constraints and audiences, yet the visual experience and user journey had to remain consistent. Additionally, the content needed to present complex scientific information—including molecules in various stages of development—while remaining digestible and engaging for time-pressed medical professionals.
The Solution
2Pixels developed a multi-platform, interactive pipeline explorer that presented detailed information on each molecule in development. Users could filter by clinical phase or tumor type, access 3D molecular models, and explore how each candidate fit into Systimmune’s broader oncology strategy. QR codes were embedded throughout the exhibit, allowing attendees to instantly access the pipeline on their own phones and link directly to Clinical Trial information for deeper exploration. The experience was optimized for exhibit kiosks, mobile use, and web, ensuring consistency and accessibility across all platforms.
Cross-Platform Compatibility
Advance Filtering System
Integrated 3D Molecular Structures
Responsive HTML-5 Framework
QR Code With Data Tracking
Final Result
2Pixels developed a multi-platform, interactive pipeline explorer that presented detailed information on each molecule in development. Users could filter by clinical phase or tumor type, access 3D molecular models, and explore how each candidate fit into Systimmune’s broader oncology strategy. QR codes were embedded throughout the exhibit, allowing attendees to instantly access the pipeline on their own phones and link directly to Clinical Trial information for deeper exploration. The experience was optimized for exhibit kiosks, mobile use, and web, ensuring consistency and accessibility across all platforms.
